There is no case of the highly contagious Delta variant in Muntinlupa, according to the City Health Office (CHO).
On Sunday, the Department of Health (DOH), University of the Philippines’ Philippine Genome Center (UP-PGC) and University of the Philippines National Institutes of Health reported 55 new cases of the Delta variant in the country bringing the total to 119.
The Delta variant is a strain of SARS-CoV-2, the virus which causes the coronavirus disease (COVID-19).
According to Dr. Juancho Bunyi, Muntinlupa City health officer, based on DOH and UP-PGC’s report as of July 25, “no reported Delta variant in Muntinlupa City.”
There are seven cases of Alpha variant, first identified in the United Kingdom, and 26 cases of Beta variant, first identified in South Africa, in Muntinlupa but all the patients have recovered. There are two new reported cases of the Beta variant in the city but they have completed the 14-day isolation and are tagged as recovered.
Mayor Jaime Fresnedi said while there is no case of the Delta variant in Muntinlupa, the city government continues to strengthen its COVID-19 response.
He is encouraging people to get vaccinated and complete their doses to get protection against COVID-19.
Compared to other variants, he said, the Delta variant is more contagious but with the vaccine, people can get complete protection against getting a severe case of COVID-19.
As of July 25, Muntinlupa has 324 active COVID-19 cases out of 14,499 confirmed cases, 13,791 recoveries, and 384 deaths.
The Muntinlupa City government has administered 273,783 doses of COVID-19 vaccines as of July 23. Of the total, 170,754 individuals have received their first dose, or 44.3 percent of the target population of 385,725. In addition, 103,029 individuals are now fully vaccinated, or 26.7 percent of the target.
According to Bunyi, the CHO has advised all health workers to implement the following to prevent the possible entry of the Delta variant into the city:
1. Aggressive contact tracing and ensuring case findings
2. Increased risk-based and targeted testing
3. Immediate isolation/quarantine of suspect/probable cases and close contacts
4. Immediate availment of vaccines and completion of doses as scheduled.
5. Strict adherence to health protocols